DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» CD30
CD30
Human Angiogenin Fused to Human CD30 Ligand (Ang-CD30L) Exhibits Specific Cytotoxicity Against CD30-Positive Lymphoma1
Tools for Cell Therapy and Immunoregulation
Autologous T Cells Expressing CD30 Chimeric Antigen Receptors For
Clinical Trials of CAR-T Cells in China Bingshan Liu1,2, Yongping Song2* and Delong Liu2*
CD134/OX40 Code No
Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy
CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30 And
CD30 Induction of Human Immunodeficiency Virus Gene Transcription Is Mediated by TRAF2
Molecular Biology of Hodgkin Lymphoma
Relation of CD30 Expression to Survival and Morphology in Large Cell B Cell Lymphomas J Clin Pathol: First Published As 10.1136/Jcp.47.1.33 on 1 January 1994
B-Cell Maturation Antigen Expression Across Hematologic Cancers: a Systematic Literature Review
Download of These Slides, Please Direct Your Browser to the Following Web Address
Human Alloimmune Responses Proliferating T Lymphocyte
Immune Therapies for Hematologic Malignancies
Human CD30 ELISA Kit (ARG81684)
Datasheet Blank Template
Contribution of CD30/CD153 but Not of CD27/CD70, CD134/OX40L, Or
Mouse CD Marker Chart Bdbiosciences.Com/Cdmarkers
Top View
Actualizing the Untapped Potential of the Innate Immune System Affimed’S Approach to Advancing Immuno-Oncology
Junb Induced by Constitutive CD30–Extracellular Signal-Regulated
Differential Signaling Via Tumor Necrosis Factor-Associated Factors (Trafs) by CD27 and CD40 in Mouse B Cells
FDA Listing of Established Pharmacologic Class Text Phrases January 2021
Genieplex Quantitative Multiplex Immunoassays
Expression in CD30 Lymphomas and Lymphomatoid Papulosis
Jan-2019-Drug-Intell
Primary Chicken and Duck Endothelial Cells Display a Differential Response to Infection with Highly Pathogenic Avian Influenza Virus
Neonatal and Adult CD4 CD3 Cells Share Similar Gene Expression
Understanding CD30 Biology and Therapeutic Targeting: a Historical Perspective Providing Insight Into Future Directions
The Role of Cd30: New Frontiers in Targeting Therapy for Malignant Lymphomas
(OX40) Proliferation in the Absence of CD134 Robust B Cell Immunity But
ADCETRIS Safely and Effectively
Antibody-Drug Conjugates in Clinical Trials for Lymphoid Malignancies and Multiple Myeloma Bo Yu1 and Delong Liu2,3*
CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas
CD30-Dependent Degradation of TRAF2: Implications for Negative Regulation of TRAF Signaling and the Control of Cell Survival
Human CD30/TNFRSF8 Alexa Fluor® 700-Conjugated Antibody
Protocol Page